BACKGROUND:Since the introduction of rotavirus vaccines, acute gastroenteritis (AGE) hospitalizations due to rotavirus have decreased globally; however, vaccine effectiveness (VE) differs by country, age and disease severity. We evaluated rotavirus VE by disease severity in different age groups and under-5 childhood mortality (U5M) strata. METHODS:The Vesikari score is a common measure of AGE disease severity. A modified Vesikari Score (mVS) was calculated for 18,426 children with medically attended AGE across 16 countries from the Multi-National Subpopulations Study To Evaluate Rotavirus Vaccines dataset. Using a test-negative case-control design (cases had rotavirus-positive AGE and controls had rotavirus-negative AGE), we calculated complete rotavirus series VE against different severity categories among children 6-59 months old, stratified by age and country U5M level, respectively. RESULTS:VE increased with increasing disease severity: 38% (95% confidence interval [CI]:17-53) for mild/moderate disease versus 58% (95% CI: 50-64) for severe/very severe disease, and this pattern persisted with stratification by age and U5M. Among children with severe/very severe disease, VE was higher in infants aged 6-11 months (62%, 95% CI: 51-70) compared with children aged 24-59 months (11%, 95% CI: -78 to 56), and lower among children in the highest U5M strata (44%, 95% CI: 26-58) compared to children in the high U5M strata (60%, 95% CI: 47-69). CONCLUSIONS:Rotavirus vaccines provide the greatest protection against very severe rotavirus disease. VE remains lower in countries with higher U5M levels, even among children with very severe rotavirus disease, highlighting the need for improved vaccine performance in countries with high disease burden.
Background Persistence of iodine deficiency disorders (IDD) and endemic goiter in sub-Saharan Africa (SSA) is multifactorial, involving not only inadequate iodine intake but also other co-dietary factors. Objective This systematic review synthesized evidence from primary human research on the roles of thiocyanate (SCN) overload/dietary goitrogens, poor dietary diversity, and selenium/iron co-deficiencies in sustaining IDD and endemic goiter in SSA populations. Methods Reported in accordance with PRISMA 2020 guidelines, the review searched PubMed, Embase, Web of Science, and African Index Medicus for studies published primarily from 1990 onward. Eligible studies were original observational or interventional human research conducted in SSA that quantitatively assessed at least one specified co-dietary factor in relation to goiter prevalence, urinary iodine concentration (UIC), or thyroid function. Results The SCN overload was associated with elevated goiter risk (Adjusted Odds Ratio [AOR] up to 3.74), reduced UIC, and biochemical interference with iodide uptake and thyroid peroxidase activity. Poor dietary diversity independently increased goiter odds (AOR up to 3.32) through reliance on monotonous staples. Selenium co-deficiency impaired deiodinase activity and antioxidant protection, while iron co-deficiency significantly reduced the efficacy of iodine repletion, halving thyroid volume reduction and doubling goiter persistence in children with anemia. These factors frequently interacted, sustaining high goiter prevalence (16-100%) despite varying USI coverage and median UIC values often approaching sufficiency (65.5-152 μg/L). Conclusion These findings highlight the need for integrated interventions beyond USI alone, including improved food processing to reduce goitrogenic potential, promotion of dietary diversity, and targeted multi-micronutrient supplementation to achieve sustainable IDD control.
Background: Blood transfusion is a critical intervention for severe anemia, hemorrhage, and other life-threatening conditions. However, transfusions carry risks such as circulatory overload, transfusion-related acute lung injury, and hemolytic reactions. Data on transfusion practices and patient perceptions in Rwanda are limited. This study aimed to characterize transfusion indications and adverse events, and assess patient knowledge and attitudes, in the internal medicine wards of the University Teaching Hospital of Kigali (CHUK). Methods: We performed a retrospective chart review of all adult patients (≥ 15 years) who received blood transfusions on the internal medicine wards from January 2020 through December 2021. Demographics, diagnoses, and documented transfusion reactions were recorded. Additionally, a prospective survey (April–May 2023) of transfused patients used a structured questionnaire to assess knowledge of indications, awareness of side effects, and willingness to accept transfusion. Data were analyzed using SPSS version 25; categorical variables were summarized as frequencies and percentages, and associations tested using chi-square or Fisher’s exact test as appropriate. Ethics approval was obtained from the University of Rwanda and CHUK, and informed consent was obtained for all interviews. Results: During the two years, 307 transfusions were given to 280 patients (51.5% female; 62% aged 30–65 years, mean ≈ 54 years). The most common underlying conditions were HIV infection (14.0%), chronic kidney disease (13.4%), and upper gastrointestinal bleeding or gastric cancer (~ 15% combined). Only 10 reactions (3.25%) were recorded, most frequently fever (0.6%). In the prospective survey (n = 71), 94.4% reported receiving a transfusion for anemia, 46.5% could not identify other indications, and 80.3% knew of no side effects. Despite limited knowledge, 88.7% were willing to accept transfusion if recommended, while 35.7% expressed concern about disease transmission. Post-transfusion symptoms included fever (7%), chills (5.6%), and dizziness (4.2%), while 70.4% reported none. Conclusions: In this tertiary-care Rwandan setting, blood transfusions were primarily used for chronic anemia associated with HIV and kidney disease. Documented adverse reactions were rare, though likely under-reported. Patients showed high acceptance but limited awareness of transfusion risks, underscoring the need for stronger hemovigilance and targeted patient education.
Background Consultation liaison psychiatry (CLP) remains a minimally researched area in sub-Saharan Africa. This study examined the profiles of patients referred for psychiatric consultation at the University Teaching Hospital Kigali (CHUK), Rwanda. Methods All adult patients who were referred or consulted for psychiatry evaluation between September to December 2024 were included, and descriptive analysis was conducted. Further in-depth individual interview of non-mental health specialists was employed. Result A total of 53 adult patients were received from other non-mental health departments. The median age was 38 years (IQR: 27-49), and the patients were predominantly female (n=36, 68%). Internal Medicine was the most frequent source of consultation, accounting for 32.7% (n=17) of referrals. From the outpatient consultation, the most common psychiatric diagnosis was somatic symptom disorder (n=13, 34.2%), followed by major depressive disorder (n=10, 26.3%). Among inpatients, delirium was the most common psychiatric diagnosis (7/15). Most of the patients were managed by either psychotherapy (n=19, 35.8%), or psychotherapy plus psychotropic medication (n=18, 34%). In-depth individual interviews with seven non-mental health specialists revealed general satisfaction with the CLP service of the hospital, with further room to improve the service by continuity of care and integrated communication. Conclusion The profile of patients referred for CLP service at CHUK closely resembles researches from other Sub-Saharan countries, with predominance of depression and delirium diagnoses. Providing multidisciplinary care for patients with comorbid medical and psychiatric conditions is essential for achieving improved health outcomes.